Matteo M. Naldini
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.
Journal: NPJ precision oncology
Published: February 03, 2026
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice.
Journal: Cancer treatment reviews
Published: December 05, 2025
Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 10, 2025
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells.
Journal: Cell reports. Medicine
Published: March 22, 2024
Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cells.
Journal: Nature biotechnology
Published: January 25, 2024
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice.
Journal: Frontiers in oncology
Published: January 22, 2024
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 09, 2023
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Journal: Cancer treatment reviews
Published: August 04, 2023
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: March 17, 2023
Last Updated: 09/26/2026